Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+14.6%
5Y CAGR+33.3%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+14.6%/yr
Annual compound
5Y CAGR
+33.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$552.60M+13.5%
2024$486.82M+43.2%
2023$340.04M-7.4%
2022$367.10M+28.7%
2021$285.23M+117.5%
2020$131.14M+434.4%
2019$24.54M-